The field of regenerative medicine is poised to revolutionize healthcare by 2030. With rapid advancements in stem cell therapy, gene therapy, and tissue engineering, this innovative sector offers groundbreaking treatments for a wide array of health conditions. From chronic diseases to injuries and
The US Food and Drug Administration (FDA) raised serious concerns about Sanofi's manufacturing facility in Framingham, Massachusetts, by issuing a Warning Letter for significant deviations from current Good Manufacturing Practice (cGMP) standards for drug substance production. This alarming
The rise of avian influenza presents a significant threat to both domestic and wild bird populations, making it imperative to adopt robust biosecurity measures to prevent its spread. This issue is increasingly pressing, especially considering recent reports of bird flu virus detections in various
In an optimistic outlook at the 43rd JPM Conference in San Francisco, Thermo Fisher CEO Marc Casper underscored the firm's strategic adaptations and growth initiatives tailored to meet surging demand for GLP-1 diabetes and weight loss products. Thermo Fisher Scientific's extensive investment in its
Makerere University in Kampala, Uganda recently unveiled a groundbreaking initiative during its 75th graduation ceremony, targeting enhanced security measures for laboratory safety and administrative protocols. In collaboration with the Uganda Virus Research Institute (UVRI) and backed by the
The integration of CRISPR technology with biomaterials engineering offers a promising avenue for safer and more effective gene therapies. Tomas Gonzalez-Fernandez, an assistant professor at Lehigh University, has received funding from the National Science Foundation’s Faculty Early Career
